Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760

Watchlist Manager
Shenzhen Mindray Bio-Medical Electronics Co Ltd Logo
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Watchlist
Price: 254.97 CNY 0.46% Market Closed
Market Cap: 309.1B CNY
Have any thoughts about
Shenzhen Mindray Bio-Medical Electronics Co Ltd?
Write Note

Profitability Summary

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
Shenzhen Mindray Bio-Medical Electronics Co Ltd

Revenue
37.1B CNY
Cost of Revenue
-13.3B CNY
Gross Profit
23.8B CNY
Operating Expenses
-10.5B CNY
Operating Income
13.3B CNY
Other Expenses
-936.4m CNY
Net Income
12.4B CNY

Margins Comparison
Shenzhen Mindray Bio-Medical Electronics Co Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
309.1B CNY
64%
36%
33%
US
Abbott Laboratories
NYSE:ABT
198.3B USD
56%
17%
14%
US
Intuitive Surgical Inc
NASDAQ:ISRG
189.1B USD
67%
26%
29%
US
Stryker Corp
NYSE:SYK
140.4B USD
64%
22%
16%
US
Boston Scientific Corp
NYSE:BSX
132.3B USD
69%
18%
11%
IE
Medtronic PLC
NYSE:MDT
104.2B USD
65%
19%
13%
US
Becton Dickinson and Co
NYSE:BDX
65.2B USD
45%
14%
9%
DE
Siemens Healthineers AG
XETRA:SHL
58.1B EUR
38%
12%
8%
US
Edwards Lifesciences Corp
NYSE:EW
44.1B USD
79%
28%
74%
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
36.2B USD
41%
13%
9%
US
IDEXX Laboratories Inc
NASDAQ:IDXX
34B USD
61%
29%
23%
Country CN
Market Cap 309.1B CNY
Gross Margin
64%
Operating Margin
36%
Net Margin
33%
Country US
Market Cap 198.3B USD
Gross Margin
56%
Operating Margin
17%
Net Margin
14%
Country US
Market Cap 189.1B USD
Gross Margin
67%
Operating Margin
26%
Net Margin
29%
Country US
Market Cap 140.4B USD
Gross Margin
64%
Operating Margin
22%
Net Margin
16%
Country US
Market Cap 132.3B USD
Gross Margin
69%
Operating Margin
18%
Net Margin
11%
Country IE
Market Cap 104.2B USD
Gross Margin
65%
Operating Margin
19%
Net Margin
13%
Country US
Market Cap 65.2B USD
Gross Margin
45%
Operating Margin
14%
Net Margin
9%
Country DE
Market Cap 58.1B EUR
Gross Margin
38%
Operating Margin
12%
Net Margin
8%
Country US
Market Cap 44.1B USD
Gross Margin
79%
Operating Margin
28%
Net Margin
74%
Country US
Market Cap 36.2B USD
Gross Margin
41%
Operating Margin
13%
Net Margin
9%
Country US
Market Cap 34B USD
Gross Margin
61%
Operating Margin
29%
Net Margin
23%
No Stocks Found

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
Shenzhen Mindray Bio-Medical Electronics Co Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
309.1B CNY
33%
22%
30%
37%
US
Abbott Laboratories
NYSE:ABT
198.3B USD
15%
8%
12%
10%
US
Intuitive Surgical Inc
NASDAQ:ISRG
189.1B USD
16%
14%
14%
19%
US
Stryker Corp
NYSE:SYK
140.4B USD
19%
9%
14%
11%
US
Boston Scientific Corp
NYSE:BSX
132.3B USD
9%
5%
9%
7%
IE
Medtronic PLC
NYSE:MDT
104.2B USD
9%
5%
8%
7%
US
Becton Dickinson and Co
NYSE:BDX
65.2B USD
7%
3%
6%
5%
DE
Siemens Healthineers AG
XETRA:SHL
58.1B EUR
11%
4%
8%
5%
US
Edwards Lifesciences Corp
NYSE:EW
44.1B USD
51%
37%
16%
18%
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
36.2B USD
22%
5%
10%
7%
US
IDEXX Laboratories Inc
NASDAQ:IDXX
34B USD
59%
27%
50%
32%
Country CN
Market Cap 309.1B CNY
ROE
33%
ROA
22%
ROCE
30%
ROIC
37%
Country US
Market Cap 198.3B USD
ROE
15%
ROA
8%
ROCE
12%
ROIC
10%
Country US
Market Cap 189.1B USD
ROE
16%
ROA
14%
ROCE
14%
ROIC
19%
Country US
Market Cap 140.4B USD
ROE
19%
ROA
9%
ROCE
14%
ROIC
11%
Country US
Market Cap 132.3B USD
ROE
9%
ROA
5%
ROCE
9%
ROIC
7%
Country IE
Market Cap 104.2B USD
ROE
9%
ROA
5%
ROCE
8%
ROIC
7%
Country US
Market Cap 65.2B USD
ROE
7%
ROA
3%
ROCE
6%
ROIC
5%
Country DE
Market Cap 58.1B EUR
ROE
11%
ROA
4%
ROCE
8%
ROIC
5%
Country US
Market Cap 44.1B USD
ROE
51%
ROA
37%
ROCE
16%
ROIC
18%
Country US
Market Cap 36.2B USD
ROE
22%
ROA
5%
ROCE
10%
ROIC
7%
Country US
Market Cap 34B USD
ROE
59%
ROA
27%
ROCE
50%
ROIC
32%
No Stocks Found

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Discover More
Back to Top